Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Kentaro Machida, Tomotaka Kawayama, Masaharu Kinoshita, Masakazu Ichinose, Tohru Tsuda, Shohei Takata, Hiroshi Koto, Makoto Yoshida, Yoshinori Ashihara, Masaru Kawashima, Hideaki Suna & Hiromasa Inoue. (2019) Imidafenacin, An Orally Active Muscarinic Receptor Antagonist, Improves Pulmonary Function In Patients With Chronic Obstructive Pulmonary Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled 3×3 Crossover Phase II Trial. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2175-2184.
Read now
Read now
Naoya Masumori. (2013) Long-term safety, efficacy, and tolerability of imidafenacin in the treatment of overactive bladder: a review of the Japanese literature. Patient Preference and Adherence 7, pages 111-120.
Read now
Read now
Umberto Leone Roberti Maggiore, Carolina Scala, Pier Luigi Venturini & Simone Ferrero. (2013)
Imidafenacin for the treatment of overactive bladder. Expert Opinion on Pharmacotherapy 14:10, pages 1383-1397.
Read now
Read now
Umberto Leone Roberti Maggiore, Stefano Salvatore, Franco Alessandri, Valentino Remorgida, Massimo Origoni, Massimo Candiani, Pier Luigi Venturini & Simone Ferrero. (2012) Pharmacokinetics and toxicity of antimuscarinic drugs for overactive bladder treatment in females. Expert Opinion on Drug Metabolism & Toxicology 8:11, pages 1387-1408.
Read now
Read now
Articles from other publishers (25)
Sascha K Manier, Johannes Angert Valdiviezo, Aline C Vollmer, Niels Eckstein & Markus R Meyer. (2023) Analytical toxicology of the semi-synthetic cannabinoid hexahydrocannabinol studied in human samples, pooled human liver S9 fraction, rat samples and drug products using HPLC–HRMS-MS. Journal of Analytical Toxicology 47:9, pages 818-825.
Crossref
Crossref
Martin C. Michel, Linda Cardozo, Christopher J. Chermansky, Francisco Cruz, Yasuhiko Igawa, Kyu-Sung Lee, Arun Sahai, Alan J. Wein & Karl-Erik Andersson. (2023) Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders. Pharmacological Reviews 75:4, pages 554-674.
Crossref
Crossref
Evgenyi I. Kreydin, Cristiano M. Gomes & Francisco Cruz. (2021) Current pharmacotherapy of overactive bladder. International braz j urol 47:6, pages 1091-1107.
Crossref
Crossref
Matteo Balzarro & Alessandro Antonelli. 2021. Non-Neurogenic Bladder Dysfunctions. Non-Neurogenic Bladder Dysfunctions
27
42
.
Mediha Süleymanoğlu, Serap Erdem‐Kuruca, Tülay Bal‐Demirci, Namık Özdemir, Bahri Ülküseven & İlhan Yaylım. (2020) Synthesis, structural, cytotoxic and pharmacokinetic evaluation of some thiosemicarbazone derivatives. Journal of Biochemical and Molecular Toxicology 34:8.
Crossref
Crossref
Dongwei Kang, Da Feng, Yanying Sun, Zengjun Fang, Fenju Wei, Erik De Clercq, Christophe Pannecouque, Xinyong Liu & Peng Zhan. (2020) Structure-Based Bioisosterism Yields HIV-1 NNRTIs with Improved Drug-Resistance Profiles and Favorable Pharmacokinetic Properties. Journal of Medicinal Chemistry 63:9, pages 4837-4848.
Crossref
Crossref
Kuanglei Wang, Hongxi Zhu, Hongqian Zhao, Kun Zhang & Yongshou Tian. (2020) Application of carbamyl in structural optimization. Bioorganic Chemistry 98, pages 103757.
Crossref
Crossref
Tamer Z. Attia, Taku Yamashita, Hirofumi Tsujino, Sayed M. Derayea, Yasuo Tsutsumi & Tadayuki Uno. (2019) Effect of Drug Combination on Omeprazole Metabolism by Cytochrome P450 2C19 in <i>Helicobacter pylori</i> Eradication Therapy. Chemical and Pharmaceutical Bulletin 67:8, pages 810-815.
Crossref
Crossref
Dongwei Kang, Tong Zhao, Zhao Wang, Da Feng, Heng Zhang, Boshi Huang, Gaochan Wu, Fenju Wei, Zhongxia Zhou, Lanlan Jing, Xiaofang Zuo, Ye Tian, Vasanthanathan Poongavanam, Jacob Kongsted, Erik De Clercq, Christophe Pannecouque, Peng Zhan & Xinyong Liu. (2019) Discovery of piperidine-substituted thiazolo[5,4-d]pyrimidine derivatives as potent and orally bioavailable HIV-1 non-nucleoside reverse transcriptase inhibitors. Communications Chemistry 2:1.
Crossref
Crossref
Ariana L. Smith & Alan J. Wein. 2019. Contemporary Pharmacotherapy of Overactive Bladder. Contemporary Pharmacotherapy of Overactive Bladder
85
113
.
Taek Hwan Shin, Sung Hyun Im, Min Su Goh, Eun Seok Lee, Myoung Jin Ho, Chang Hyun Kim, Myung Joo Kang & Young Wook Choi. (2018) Novel Extended-Release Multiple-Unit System of Imidafenacin Prepared by Fluid-Bed Coating Technique. AAPS PharmSciTech 19:6, pages 2639-2645.
Crossref
Crossref
Sascha K. Manier, Lilian H.J. Richter, Jan Schäper, Hans H. Maurer & Markus R. Meyer. (2018) Different in vitro and in vivo tools for elucidating the human metabolism of alpha‐cathinone‐derived drugs of abuse. Drug Testing and Analysis 10:7, pages 1119-1130.
Crossref
Crossref
Julie Ducharme & Karine Auclair. (2018) Use of bioconjugation with cytochrome P450 enzymes. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1866:1, pages 32-51.
Crossref
Crossref
Karl-Erik Andersson. 2014. Bladder Dysfunction in the Adult. Bladder Dysfunction in the Adult
121
222
.
Takumi Takeuchi, Masayoshi Zaitsu & Koji Mikami. (2012) Experience with imidafenacin in the management of overactive bladder disorder. Therapeutic Advances in Urology 5:1, pages 43-58.
Crossref
Crossref
Chihiro Hasegawa, Tomoya Ohno, Susumu Nakade, Kimio Shibakawa, Hiroyuki Miyabe, Takafumi Ouchi & Mikio Ogawa. (2013) Population Pharmacokinetics and Exposure–response Relationship of a Muscarinic Receptor Antagonist, Imidafenacin. Drug Metabolism and Pharmacokinetics 28:3, pages 203-212.
Crossref
Crossref
Valentina E. V. Ferrero, Giovanna Di Nardo, Gianluca Catucci, Sheila J. Sadeghi & Gianfranco Gilardi. (2012) Fluorescence detection of ligand binding to labeled cytochrome P450BM3. Dalton Trans. 41:7, pages 2018-2025.
Crossref
Crossref
Susumu Nakade, Tomoya Ohno & Mikio Ogawa. (2009) Response to ?Suspected Differential Interactions of Digoxin with Imidafenacin and Propantheline; Some Thoughts for Introspection?. Drug Metabolism and Pharmacokinetics 24:5, pages 486-487.
Crossref
Crossref
Nuggehally R. Srinivas. (2009) Suspected Differential Interactions of Digoxin with Imidafenacin and Propantheline; Some Thoughts for Introspection. Drug Metabolism and Pharmacokinetics 24:2, pages 194-196.
Crossref
Crossref
Ying Liu, Jianjie Jiao, Caili Zhang & Jianshi Lou. (2009) A Simplified Method to Determine Five Cytochrome P450 Probe Drugs by HPLC in a Single Run. Biological & Pharmaceutical Bulletin 32:4, pages 717-720.
Crossref
Crossref
Valentina E. V. Ferrero, Laura Andolfi, Giovanna Di Nardo, Sheila J. Sadeghi, Andrea Fantuzzi, Salvatore Cannistraro & Gianfranco Gilardi. (2008) Protein and Electrode Engineering for the Covalent Immobilization of P450 BMP on Gold. Analytical Chemistry 80:22, pages 8438-8446.
Crossref
Crossref
Tomoya Ohno, Kazuki Nakayama, Susumu Nakade, Junsaku Kitagawa, Shinya Ueda, Hiroyuki Miyabe, Yasuyuki Miyata & Akihiro Ohnishi. (2013) Effect of Itraconazole on the Pharmacokinetics of Imidafenacin in Healthy Subjects. The Journal of Clinical Pharmacology 48:3, pages 330-334.
Crossref
Crossref
Susumu Nakade, Tomoya Ohno, Kazuki Nakayama, Junsaku Kitagawa, Yoshitaka Hashimoto, Akihiro Ohnishi & Yasuyuki Miyata. (2008) No Effect of Imidafenacin, a Novel Antimuscarinic Drug, on Digoxin Pharmacokinetics in Healthy Subjects. Drug Metabolism and Pharmacokinetics 23:2, pages 95-100.
Crossref
Crossref
Tomoya Ohno, Susumu Nakade, Kazuki Nakayama, Junsaku Kitagawa, Hiroyuki Miyabe, Toshihiko Konomi & Yasuyuki Miyata. (2008) Population Pharmacokinetic Analysis of a Novel Muscarinic Receptor Antagonist, Imidafenacin, in Healthy Volunteers and Overactive Bladder Patients. Drug Metabolism and Pharmacokinetics 23:6, pages 456-463.
Crossref
Crossref
Satoshi Ohmori, Masahiro Miura, Chifuyu Toriumi, Yoshiaki Satoh & Tsuyoshi Ooie. (2007)
Absorption, Metabolism, and Excretion of [
14
C]Imidafenacin, a New Compound for Treatment of Overactive Bladder, After Oral Administration to Healthy Male Subjects
. Drug Metabolism and Disposition 35:9, pages 1624-1633.
Crossref
Crossref